dihexa intranasal Peptide DIHEXA | Peptide Synthetic |

BPC157 is commonly studied in preclinical models related to tissuerepair signaling, cell migration, extracellular matrix dynamics, and vascular (bloodvessel) signaling

The combination of these two medicines has led to significant weight loss and improved glycemic control in adults with obesity or overweight during clinical trials

Experimental Injury Treatment : Laboratory models explore BPC-157 in wound healing and tissue regeneration, which connects to experimental therapeutic approaches

Lack of approval reflects insufficient human clinical trial data and incomplete evaluation of risks, dosing, and long-term effects